📰 Plasma Cell News
Plasma Cell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Plasma Cell. Real-time updates on events, politics, business and more.
February 20, 2024
/PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...
August 10, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted...
June 5, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that results from the Phase 3 CARTITUDE-4 study showed CARVYKTI®...
June 5, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today long-term data from the pivotal Phase 1/2 MajesTEC-1 study showing...
June 3, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first-ever results from the Phase 1b RedirecTT-1 study of...
April 26, 2023
/PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to...
January 27, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI®...
December 24, 2022
A lymph node with clusters of germinal centers full of mature B cells (red), dotted with less evolved “naive” B cells (green).
November 14, 2022
Singleron to present novel single cell sequencing solutions for blood cancer research at the 64th ASH Annual Meeting & Exposition GlobeNewswire November 14, 2022 COLOGNE, Germany, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions for precision medicine, announced today...
November 14, 2022
COLOGNE, Germany, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell...